ARTICLE | Clinical News
Gliatech regulatory update
April 15, 2013 7:00 AM UTC
GLIA received U.S. Patent No. 5,605,938 covering methods and composition claims encompassing portions of the company's Adcon technology, which includes Adcon-L and Adcon-T/N anti-adhesion barrier gels...